Ernst Forjan
Hanusch Hospital(AT)
Publications by Year
Research Areas
Myeloproliferative Neoplasms: Diagnosis and Treatment, Lymphoma Diagnosis and Treatment, Acute Myeloid Leukemia Research, Platelet Disorders and Treatments, Chronic Lymphocytic Leukemia Research
Most-Cited Works
- → Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study(2020)333 cited
- → Impact of platelets on major thrombosis in patients with a normal white blood cell count in essential thrombocythemia(2020)16 cited
- → Long-Term Efficacy and Safety of Ropeginterferon Alfa-2b in Patients with Polycythemia Vera — Final Phase I/II Peginvera Study Results(2018)16 cited
- → CPX‐351 (Vyxeos®) can cause severe rash in acute myeloid leukemia—A case report(2021)7 cited
- → Screening and Confirmatory Testing for SARS-CoV-2 Antibodies: Comparison of Health and Non-Health Workers in a Nationwide Healthcare Organization in Central Europe(2021)2 cited
- → CPX-351 (Vyxeos®) can cause severe rash in acute myeloid leukaemia – a case report(2020)
- → COMORBIDITY & CLL DIFFERENT SCORES – DIFFERENT RESULTS(2023)
- → Long-Time Follow-up of 888 Patients Diagnosed with CLL on a Single Center: Comorbidities, Time-to-Treatment and Comparison between Treated and Untreated Patients(2019)
- → PS1470 EFFICACY AND SAFETY OF ANAGRELIDE IN OLDER PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA(2019)